Fritextsökning
Innehållstyper
-
“Unfortunately, we are not strong when it comes to conducting clinical trials”
The number of company-initiated clinical trials conducted in Sweden has been declining in recent years. In mid-March, a government inquiry was presented that ai...
-
Faster development of reliable sample handling
Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...
-
Stockholm och Uppsala bildar gemensamt life science-kluster
Stockholm och Uppsala stärker samarbetet inom medicinsk forskning och biotech.
-
Nanoparticles to help detect pulmonary disease
Nanoparticles behave in a certain way in the air. Using this knowledge, researchers at Lund University have developed a new measurement method for lung examinat...
-
“Don’t postpone the transition to IVDR”
Operators who have not yet started to adapt to the requirements of the new EU IVDR regulation are running out of excuses. This is the opinion of Helena Dzojic, ...
-
Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience
Case study by ZEISS Microscopy.
-
Setback for pharmaceutical companies in the Zantac case
A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.
-
Nanexa develops depot formulation of the diabetes and obesity drug Saxenda
Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...
-
Vill du ha något att läsa på sommarsemestern?
Vid bassängkanten, på tågresan eller i hängmattan kan det bli tid över för läsning. Här tipsar vi om några av de texter Life Science Sweden publicerat tidigare i år.
-
A growing industry in Denmark: “One new life science company a week”
The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage...
-
Implantatföretags grundare lämnar vd-posten
Medtechbolaget Integrums grundare Rickard Brånemark lämnar vd-posten och får i stället en rådgivande roll i bolaget. Ny tillförordnad vd är styrelseledamoten Scott Flora.
-
Sobi planerar EMA-ansökan efter positiva studiedata för njurbehandling
Det svenska särläkemedelsbolaget Sobi rapporterar positiva resultat från en fas III-studie med företagets läkemedelskandidat pegcetacoplan mot två sällsynta nju...
-
Bioarctic granted Japanese patent for Parkinson’s disease candidate
Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.
-
Riksrevisionen ser brister i tillsynen av medicinteknik
Tillsynen över medicintekniska produkter är otillräcklig och felriktad, menar Riksrevisionen i en granskningsrapport där både Läkemedelsverket och Ivo får sig en känga.
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...
-
The Oresund region aims at becoming Europe’s microbiome Mecca
The Medicon Valley Alliance’s ambition: Skåne and the Copenhagen region will become world leaders in microbiome research.
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
Mathias Uhlén’s protein atlas is recognised as a global resource
The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...
-
Ojämlik cancerscreening kostar liv
Låginkomsttagare deltar i mindre grad i cancerscreening än höginkomsttagare, enligt en rapport från Cancerfonden som beräknar att 194 fler liv kunde räddas med ...
-
Positiva resultat i ny cancerstudie med Imfinzi
Läkemedelsbolaget Astra Zenecas läkemedel Imfinzi (durvalumab), förbättrade signifikant den totala överlevnaden och progressionsfri överlevnad för patienter med...
-
Gothenburg-based company acquired by Norwegian diagnostics group
Gentian Diagnostics acquires Gothenburg-based Getica.
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...
BREAKING